| AZN |
AstraZeneca
|
FTSE 100 |
1.73 |
£216.33B |
13,512.00 |
-3.13% |
| GSK |
GSK
|
FTSE 100 |
3.75 |
£78.2B |
1,901.00 |
-1.43% |
| HLN |
Haleon
|
FTSE 100 |
2.09 |
£30.23B |
344.10 |
1.21% |
| SN. |
Smith & Nephew
|
FTSE 100 |
2.44 |
£9.71B |
1,147.00 |
0.88% |
| CTEC |
ConvaTec Group
|
FTSE 100 |
2.47 |
£4.12B |
210.00 |
-0.38% |
| HIK |
Hikma Pharmaceuticals
|
FTSE 100 |
4.50 |
£3.03B |
1,408.00 |
0.68% |
| HCM |
Hutchmed China
|
AIM |
|
£1.71B |
195.00 |
4.80% |
| GNS |
Genus
|
FTSE 250 |
1.41 |
£1.56B |
2,356.00 |
0.51% |
| INDV |
Indivior
|
FTSE 250 |
|
£1.54B |
1,238.00 |
-3.10% |
| UPR |
Uniphar
|
AIM |
0.00 |
£922.88M |
348.00 |
0.90% |
| OXB |
Oxford BioMedica
|
FTSE Small Cap |
|
£725.41M |
593.00 |
-1.17% |
| SPI |
Spire Healthcare Group
|
FTSE 250 |
0.93 |
£656.5M |
164.40 |
0.86% |
| AGY |
Allergy Therapeutics
|
AIM |
|
£633.25M |
10.95 |
-2.50% |
| AMS |
Advanced Medical Solutions Group
|
AIM |
1.16 |
£533.87M |
243.00 |
3.10% |
| AVCT |
Avacta Group
|
AIM |
|
£326.36M |
72.00 |
-7.00% |
| PRTC |
Puretech Health
|
FTSE Small Cap |
|
£310.6M |
138.80 |
8.78% |
| NIOX |
Niox Group
|
AIM |
2.23 |
£292.61M |
68.00 |
% |
| BTG |
BTG
|
AIM |
3.68 |
£192.69M |
119.50 |
-0.10% |
| TSTL |
Tristel
|
AIM |
3.57 |
£190.53M |
392.00 |
1.60% |
| ANCR |
Animalcare Group
|
AIM |
2.12 |
£169.16M |
245.00 |
-2.60% |
| MXCT |
Maxcyte Inc
|
AIM |
|
£161.75M |
147.69 |
-1.20% |
| DXRX |
Diaceutics
|
AIM |
|
£146.03M |
166.00 |
-0.50% |
| SCLP |
Scancell Holdings
|
AIM |
|
£141.66M |
13.90 |
-1.10% |
| BMK |
Benchmark Holdings
|
AIM |
|
£135.69M |
22.05 |
1.50% |
| EKF |
EKF Diagnostics Holdings
|
AIM |
|
£111.93M |
26.70 |
1.00% |
| ANP |
Anpario
|
AIM |
2.40 |
£107.1M |
520.00 |
-0.90% |
| STX |
Shield Therapeutics
|
AIM |
|
£94.02M |
8.75 |
-7.90% |
| BVXP |
Bioventix
|
AIM |
8.96 |
£87.52M |
1,703.50 |
-2.20% |
| SPEC |
Inspecs Group
|
AIM |
|
£84.9M |
82.00 |
-0.30% |
| SDI |
SDI Group
|
AIM |
|
£80.3M |
75.74 |
-1.50% |
| 4BB |
4basebio
|
AIM |
|
£78.16M |
525.45 |
-0.40% |
| FARN |
Faron Pharmaceuticals OY
|
AIM |
|
£77.21M |
41.99 |
1.10% |
| KMK |
Kromek Group
|
AIM |
|
£70.42M |
10.50 |
8.70% |
| ANIC |
Agronomics
|
AIM |
|
£70.26M |
6.78 |
-0.60% |
| EAH |
Eco Animal Health Group
|
AIM |
|
£63.02M |
93.00 |
-4.30% |
| OBI |
Ondine Biomedical Inc
|
AIM |
|
£61.05M |
11.75 |
2.60% |
| HVO |
Hvivo
|
AIM |
0.03 |
£51.53M |
7.50 |
-5.10% |
| CREO |
Creo Medical Group
|
AIM |
|
£49.3M |
13.10 |
-0.80% |
| ABDX |
Abingdon Health
|
AIM |
|
£36.84M |
8.01 |
2.60% |
| OHGR |
One Health Group
|
AIM |
0.02 |
£34.37M |
249.37 |
% |
| POLB |
Poolbeg Pharma
|
AIM |
|
£31.38M |
4.36 |
-2.10% |
| SAR |
Sareum Holdings
|
AIM |
|
£28.99M |
20.90 |
-5.60% |
| EDEN |
Eden Research
|
AIM |
|
£26.51M |
3.23 |
-2.40% |
| IMM |
ImmuPharma
|
AIM |
|
£25.58M |
4.05 |
-3.00% |
| SBTX |
SkinBioTherapeutics
|
AIM |
|
£25.27M |
9.75 |
-14.90% |
| IHC |
Inspiration Healthcare Group
|
AIM |
|
£25.2M |
30.60 |
0.60% |
| AREC |
Arecor Therapeutics
|
AIM |
|
£24.92M |
63.21 |
-1.30% |
| NCYT |
Novacyt SA
|
AIM |
|
£23.25M |
30.33 |
4.20% |
| FAB |
Fusion Antibodies
|
AIM |
|
£17.82M |
14.20 |
25.90% |
| COG |
Cambridge Cognition Holdings
|
AIM |
|
£16.29M |
36.00 |
-0.40% |
| IXI |
Ixico
|
AIM |
|
£14.99M |
6.78 |
-1.50% |
| GDR |
Genedrive
|
AIM |
|
£14.69M |
0.91 |
-1.60% |
| RUA |
RUA Life Sciences
|
AIM |
|
£12.72M |
20.01 |
-6.90% |
| CEL |
Celadon Pharmaceuticals
|
AIM |
|
£9.23M |
13.40 |
% |
| OBD |
Oxford BioDynamics
|
AIM |
|
£9.23M |
0.19 |
-4.00% |
| GENI |
Genincode
|
AIM |
|
£8.66M |
1.21 |
1.40% |
| AGL |
Angle
|
AIM |
|
£7.72M |
2.40 |
-0.70% |
| VRCI |
Verici Dx
|
AIM |
|
£7.19M |
0.46 |
-4.80% |
| FUM |
Futura Medical
|
AIM |
|
£5.17M |
0.83 |
14.60% |
| TRX |
Tissue Regenix Group
|
AIM |
|
£5.16M |
7.25 |
-1.50% |
| OPTI |
OptiBiotix Health
|
AIM |
|
£5.01M |
4.94 |
-3.30% |
| PRM |
Proteome Sciences
|
AIM |
|
£4.96M |
1.50 |
8.00% |
| MHC |
MyHealthChecked
|
AIM |
|
£4.55M |
8.75 |
5.30% |
| SUN |
Surgical Innovations Group
|
AIM |
|
£4.2M |
0.45 |
-2.30% |
| BELL |
Belluscura
|
AIM |
|
£3.01M |
0.75 |
-1.10% |
| PYC |
Physiomics
|
AIM |
|
£2.49M |
0.53 |
-3.80% |
| VAL |
ValiRx
|
AIM |
|
£2.08M |
0.27 |
-2.20% |
| GUN |
Gunsynd
|
AIM |
|
£1.39M |
0.09 |
9.50% |
| POLX |
Polarean Imaging
|
AIM |
|
– |
0.08 |
-3.20% |
| TLY |
Totally
|
AIM |
|
– |
0.24 |
-1.90% |
| TRLS |
Trellus Health
|
AIM |
|
– |
0.15 |
7.30% |